125 related articles for article (PubMed ID: 34157361)
21. CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase.
Kohno M; Hasegawa H; Miyake M; Yamamoto T; Fujita S
Int J Cancer; 2002 Jan; 97(3):336-43. PubMed ID: 11774285
[TBL] [Abstract][Full Text] [Related]
22. Tspan8 and Tspan8/CD151 knockout mice unravel the contribution of tumor and host exosomes to tumor progression.
Zhao K; Wang Z; Hackert T; Pitzer C; Zöller M
J Exp Clin Cancer Res; 2018 Dec; 37(1):312. PubMed ID: 30541597
[TBL] [Abstract][Full Text] [Related]
23. Exosomal MicroRNA MiR-1246 Promotes Cell Proliferation, Invasion and Drug Resistance by Targeting CCNG2 in Breast Cancer.
Li XJ; Ren ZJ; Tang JH; Yu Q
Cell Physiol Biochem; 2017; 44(5):1741-1748. PubMed ID: 29216623
[TBL] [Abstract][Full Text] [Related]
24. PGRN
Yue S; Ye X; Zhou T; Gan D; Qian H; Fang W; Yao M; Zhang D; Shi H; Chen T
Life Sci; 2021 Jan; 264():118687. PubMed ID: 33181174
[TBL] [Abstract][Full Text] [Related]
25. Exosomal miRNAs from highly metastatic cells can induce metastasis in non-metastatic cells.
Kia V; Mortazavi Y; Paryan M; Biglari A; Mohammadi-Yeganeh S
Life Sci; 2019 Mar; 220():162-168. PubMed ID: 30721706
[TBL] [Abstract][Full Text] [Related]
26. Key Role of CD151-integrin Complex in Lung Cancer Metastasis and Mechanisms Involved.
Peng D; Li PC; Liu T; Zeng HS; Fei YJ; Liu ZX; Zuo HJ
Curr Med Sci; 2020 Dec; 40(6):1148-1155. PubMed ID: 33428143
[TBL] [Abstract][Full Text] [Related]
27. The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers.
Risha Y; Minic Z; Ghobadloo SM; Berezovski MV
Sci Rep; 2020 Aug; 10(1):13572. PubMed ID: 32782317
[TBL] [Abstract][Full Text] [Related]
28. The Role of Exosomes in Breast Cancer.
Lowry MC; Gallagher WM; O'Driscoll L
Clin Chem; 2015 Dec; 61(12):1457-65. PubMed ID: 26467503
[TBL] [Abstract][Full Text] [Related]
29. Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells.
Hannafon BN; Gin AL; Xu YF; Bruns M; Calloway CL; Ding WQ
Cell Commun Signal; 2019 Feb; 17(1):13. PubMed ID: 30782165
[TBL] [Abstract][Full Text] [Related]
30. Exosomes secreted by mesenchymal stromal/stem cell-derived adipocytes promote breast cancer cell growth via activation of Hippo signaling pathway.
Wang S; Su X; Xu M; Xiao X; Li X; Li H; Keating A; Zhao RC
Stem Cell Res Ther; 2019 Apr; 10(1):117. PubMed ID: 30971292
[TBL] [Abstract][Full Text] [Related]
31. The migration and invasion of human prostate cancer cell lines involves CD151 expression.
Ang J; Fang BL; Ashman LK; Frauman AG
Oncol Rep; 2010 Dec; 24(6):1593-7. PubMed ID: 21042756
[TBL] [Abstract][Full Text] [Related]
32. Molecular modeling and in vitro study on pyrocatechol as potential pharmacophore of CD151 inhibitor.
Akella M; Malla R
J Mol Graph Model; 2020 Nov; 100():107681. PubMed ID: 32738620
[TBL] [Abstract][Full Text] [Related]
33. Periostin is identified as a putative metastatic marker in breast cancer-derived exosomes.
Vardaki I; Ceder S; Rutishauser D; Baltatzis G; Foukakis T; Panaretakis T
Oncotarget; 2016 Nov; 7(46):74966-74978. PubMed ID: 27589561
[TBL] [Abstract][Full Text] [Related]
34. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.
Ono M; Kosaka N; Tominaga N; Yoshioka Y; Takeshita F; Takahashi RU; Yoshida M; Tsuda H; Tamura K; Ochiya T
Sci Signal; 2014 Jul; 7(332):ra63. PubMed ID: 24985346
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer cell-derived exosomal miR-20a-5p promotes the proliferation and differentiation of osteoclasts by targeting SRCIN1.
Guo L; Zhu Y; Li L; Zhou S; Yin G; Yu G; Cui H
Cancer Med; 2019 Sep; 8(12):5687-5701. PubMed ID: 31385464
[TBL] [Abstract][Full Text] [Related]
36. Exosomes released upon mitochondrial ASncmtRNA knockdown reduce tumorigenic properties of malignant breast cancer cells.
Lobos-González L; Bustos R; Campos A; Silva V; Silva V; Jeldes E; Salomon C; Varas-Godoy M; Cáceres-Verschae A; Duran E; Vera T; Ezquer F; Ezquer M; Burzio VA; Villegas J
Sci Rep; 2020 Jan; 10(1):343. PubMed ID: 31941923
[TBL] [Abstract][Full Text] [Related]
37. Protease Cargo in Circulating Exosomes of Breast Cancer and Ovarian Cancer Patients.
Tamkovich SN; Yunusova NV; Tugutova E; Somov AK; Proskura KV; Kolomiets LA; Stakheeva MN; Grigor’eva AE; Laktionov PP; Kondakova IV
Asian Pac J Cancer Prev; 2019 Jan; 20(1):255-262. PubMed ID: 30678441
[TBL] [Abstract][Full Text] [Related]
38. Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts.
Coussy F; Lavigne M; de Koning L; Botty RE; Nemati F; Naguez A; Bataillon G; Ouine B; Dahmani A; Montaudon E; Painsec P; Chateau-Joubert S; Laetitia F; Larcher T; Vacher S; Chemlali W; Briaux A; Melaabi S; Salomon AV; Guinebretiere JM; Bieche I; Marangoni E
Theranostics; 2020; 10(4):1531-1543. PubMed ID: 32042320
[TBL] [Abstract][Full Text] [Related]
39. Proteomic Analysis of Blood Exosomes from Healthy Females and Breast Cancer Patients Reveals an Association between Different Exosomal Bioactivity on Non-tumorigenic Epithelial Cell and Breast Cancer Cell Migration in Vitro.
Tutanov O; Orlova E; Proskura K; Grigor'eva A; Yunusova N; Tsentalovich Y; Alexandrova A; Tamkovich S
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32218180
[TBL] [Abstract][Full Text] [Related]
40. Extracellular Matrix-Mediated Breast Cancer Cells Morphological Alterations, Invasiveness, and Microvesicles/Exosomes Release.
Franchi M; Piperigkou Z; Karamanos KA; Franchi L; Masola V
Cells; 2020 Sep; 9(9):. PubMed ID: 32899718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
